Antialarmins for treatment of asthma

Mitchell, 2017, Epithelial-derived cytokines in asthma, Chest, 151, 1338, 10.1016/j.chest.2016.10.042

Anto, 2017, Mechanisms of the development of allergy (MeDALL): introducing novel concepts in allergy phenotypes, J Allergy Clin Immunol, 139, 388, 10.1016/j.jaci.2016.12.940

Fajt, 2017, Development of new therapies for severe asthma, Allergy Asthma Immunol Res, 9, 3, 10.4168/aair.2017.9.1.3

Haldar, 2007, Noneosinophilic asthma: a distinct clinical and pathologic phenotype, J Allergy Clin Immunol, 119, 1043, 10.1016/j.jaci.2007.02.042

Haldar, 2009, Mepolizumab and exacerbations of refractory eosinophilic asthma, N Engl J Med, 360, 973, 10.1056/NEJMoa0808991

Kaur, 2016, Interaction between the muscle metaboreflex and the arterial baroreflex in control of arterial pressure and skeletal muscle blood flow, Am J Physiol Heart Circ Physiol, 311, H1268, 10.1152/ajpheart.00501.2016

Kaur, 2015, IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk, Allergy, 70, 556, 10.1111/all.12593

O’Byrne, 2009, Allergen-induced airway inflammation and its therapeutic intervention, Allergy Asthma Immunol Res, 1, 3, 10.4168/aair.2009.1.1.3

Gauvreau, 2015, Allergen-induced airway responses, Eur Respir J, 46, 819, 10.1183/13993003.00536-2015

Castillo, 2017, Asthma exacerbations: pathogenesis, prevention, and treatment, J Allergy Clin Immunol Pract, 5, 918, 10.1016/j.jaip.2017.05.001

Reddel, 2015, A summary of the new GINA strategy: a roadmap to asthma control, Eur Respir J, 46, 622, 10.1183/13993003.00853-2015

McCracken, 2017, Diagnosis and management of asthma in adults, JAMA, 318, 279, 10.1001/jama.2017.8372

Lugogo, 2016, Long-term efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a multicenter, open-label, Phase IIIb study, Clin Ther, 38, 2058, 10.1016/j.clinthera.2016.07.010

O’Byrne, 2017, POINT: will new antieosinophilic drugs be useful in asthma management? Yes, Chest, 151, 14, 10.1016/j.chest.2016.09.021

Poulakos, 2017, Mepolizumab for the treatment of severe eosinophilic asthma, Am J Health Syst Pharm, 74, 963, 10.2146/ajhp160291

Haldar, 2017, Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma, Biologics, 11, 81

Pelaia, 2017, Targeted therapy in severe asthma today: focus on immunoglobulin E, Drug Des Devel Ther, 11, 1979, 10.2147/DDDT.S130743

O’Byrne, 2015, Timing is everything: targeting IgE to reduce asthma exacerbation risk, J Allergy Clin Immunol, 136, 1486, 10.1016/j.jaci.2015.10.008

Canonica, 2016, Therapeutic interventions in severe asthma, World Allergy Organ J, 9, 40, 10.1186/s40413-016-0130-3

Neto, 2014, Integrative data mining highlights candidate genes for monogenic myopathies, PLoS One, 9, e110888, 10.1371/journal.pone.0110888

Cockcroft, 2000, Allergen induced increase in nonallergic airway responsiveness: a citation classic revisited, Can Respir J, 7, 182, 10.1155/2000/846798

El-Gammal, 2016, Allergen-induced changes in bone marrow and airway dendritic cells in subjects with asthma, Am J Respir Crit Care Med, 194, 169, 10.1164/rccm.201508-1623OC

Gauvreau, 2014, Effects of an anti-TSLP antibody on allergen-induced asthmatic responses, N Engl J Med, 370, 2102, 10.1056/NEJMoa1402895

Salter, 2016, IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma, Respir Res, 17, 5, 10.1186/s12931-016-0321-z

Tang, 2016, Allergen-induced increases in interleukin-25 and interleukin-25 receptor expression in mature eosinophils from atopic asthmatics, Int Arch Allergy Immunol, 170, 234, 10.1159/000449248

Tworek, 2016, IL-25 receptor expression on airway dendritic cells after allergen challenge in subjects with asthma, Am J Respir Crit Care Med, 193, 957, 10.1164/rccm.201509-1751OC

Watson, 2014, Thymic stromal lymphopoietin: a central regulator of allergic asthma, Expert Opin Ther Targets, 18, 771, 10.1517/14728222.2014.915314

Lu, 2017, One mechanism of glucocorticoid action in asthma may involve the inhibition of IL-25 expression, Exp Ther Med, 13, 657, 10.3892/etm.2016.4002

Corren, 2017, Tezepelumab in adults with uncontrolled asthma, N Engl J Med, 377, 936, 10.1056/NEJMoa1704064

Vareille, 2011, The airway epithelium: soldier in the fight against respiratory viruses, Clin Microbiol Rev, 24, 210, 10.1128/CMR.00014-10

Holgate, 2007, Epithelium dysfunction in asthma, J Allergy Clin Immunol, 120, 1233, 10.1016/j.jaci.2007.10.025

Papadopoulos, 2007, Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document, Allergy, 62, 457, 10.1111/j.1398-9995.2007.01341.x

Smelter, 2010, Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle, J Immunol, 185, 3035, 10.4049/jimmunol.1000252

Redhu, 2013, Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells, Sci Rep, 3, 2301, 10.1038/srep02301

Ferreira, 2012, Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma, Clin Exp Allergy, 42, 1459, 10.1111/j.1365-2222.2012.04047.x

Scheeren, 2010, Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation, Eur J Immunol, 40, 955, 10.1002/eji.200939419

Levin, 1999, Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism, J Immunol, 162, 677, 10.4049/jimmunol.162.2.677

Siracusa, 2011, TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation, Nature, 477, 229, 10.1038/nature10329

Salter, 2015, Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent, J Allergy Clin Immunol, 136, 1636, 10.1016/j.jaci.2015.03.039

Smith, 2015, Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma, J Allergy Clin Immunol, 135, 1594, 10.1016/j.jaci.2014.12.1918

Allakhverdi, 2009, Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells, J Allergy Clin Immunol, 123, 958, 10.1016/j.jaci.2009.01.059

Hui, 2014, The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil-basophil lineage commitment: relevance to atopic sensitization, Immun Inflamm Dis, 2, 44, 10.1002/iid3.20

Hui, 2014, T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells, Clin Exp Allergy, 44, 953, 10.1111/cea.12330

Hui, 2015, Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a function of TSLP genotype, Mucosal Immunol, 8, 993, 10.1038/mi.2014.126

Kitajima, 2011, TSLP enhances the function of helper type 2 cells, Eur J Immunol, 41, 1862, 10.1002/eji.201041195

Al-Shami, 2005, A role for TSLP in the development of inflammation in an asthma model, J Exp Med, 202, 829, 10.1084/jem.20050199

Omori, 2007, Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin, J Immunol, 178, 1396, 10.4049/jimmunol.178.3.1396

Akamatsu, 2008, Human TSLP directly enhances expansion of CD8+ T cells, Clin Exp Immunol, 154, 98, 10.1111/j.1365-2249.2008.03731.x

Wong, 2010, Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation, Am J Respir Cell Mol Biol, 43, 305, 10.1165/rcmb.2009-0168OC

Han, 2017, The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice, J Immunol, 119, 1308, 10.4049/jimmunol.1700216

Allakhverdi, 2007, Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells, J Exp Med, 204, 253, 10.1084/jem.20062211

Reche, 2001, Human thymic stromal lymphopoietin preferentially stimulates myeloid cells, J Immunol, 167, 336, 10.4049/jimmunol.167.1.336

Hirano, 2011, Human thymic stromal lymphopoietin enhances expression of CD80 in human CD14+ monocytes/macrophages, Inflamm Res, 60, 605, 10.1007/s00011-011-0310-0

Soumelis, 2002, Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP, Nat Immunol, 3, 673, 10.1038/ni805

Watanabe, 2004, Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion, Nat Immunol, 5, 426, 10.1038/ni1048

Wang, 2006, Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells, Immunity, 24, 827, 10.1016/j.immuni.2006.03.019

Akdis, 2016, Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases, J Allergy Clin Immunol, 138, 984, 10.1016/j.jaci.2016.06.033

Mjösberg, 2011, Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161, Nat Immunol, 12, 1055, 10.1038/ni.2104

Ito, 2005, TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med, 202, 1213, 10.1084/jem.20051135

Froidure, 2014, Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses, Allergy Eur J Allergy Clin Immunol, 69, 1068, 10.1111/all.12435

Wu, 2010, Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis, J Allergy Clin Immunol, 126, 290, 10.1016/j.jaci.2010.05.024

Lee, 2008, Murine thymic stromal lymphopoietin promotes the differentiation of regulatory T cells from thymic CD4(+)CD8(−)CD25(−) naïve cells in a dendritic cell-independent manner, Immunol Cell Biol, 86, 206, 10.1038/sj.icb.7100127

Nguyen, 2010, TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway, Allergy Asthma Clin Immunol, 6, 4, 10.1186/1710-1492-6-4

Lei, 2011, Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells, J Immunol, 186, 2254, 10.4049/jimmunol.1002503

Watanabe, 2005, Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus, Nature, 436, 1181, 10.1038/nature03886

Mazzucchelli, 2008, Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP, Blood, 112, 3283, 10.1182/blood-2008-02-137414

Zheng, 2017, The TH2-polarizing function of atopic interleukin 17 receptor B-positive dendritic cells up-regulated by lipopolysaccharide, Ann Allergy Asthma Immunol, 118, 474, 10.1016/j.anai.2016.12.011

Gregory, 2013, IL-25 drives remodelling in allergic airways disease induced by house dust mite, Thorax, 68, 82, 10.1136/thoraxjnl-2012-202003

Hong, 2014, Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells, J Allergy Clin Immunol, 134, 429, 10.1016/j.jaci.2014.04.020

Fujita, 2012, Interleukin-33 induces interleukin-17F in bronchial epithelial cells, Allergy Eur J Allergy Clin Immunol, 67, 744, 10.1111/j.1398-9995.2012.02825.x

Murakami-Satsutani, 2014, IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand, Allergol Int, 63, 443, 10.2332/allergolint.13-OA-0672

Bianchetti, 2012, IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma, Biochem Biophys Res Commun, 426, 116, 10.1016/j.bbrc.2012.08.047

Guo, 2014, IL-33 promotes airway remodeling and is a marker of asthma disease severity, J Asthma, 903, 1

Tanabe, 2014, IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells, Clin Exp Allergy, 44, 540, 10.1111/cea.12283

Kim, 2012, Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity, J Allergy Clin Immunol, 129, 216, 10.1016/j.jaci.2011.10.036

Bartemes, 2014, Enhanced innate type 2 immune response in peripheral blood from patients with asthma, J Allergy Clin Immunol, 134, 671, 10.1016/j.jaci.2014.06.024

Liu, 2015, Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway, J Immunol, 195, 3537, 10.4049/jimmunol.1500905

Yao, 2016, Interleukin (IL)-25: pleiotropic roles in asthma, Respirology, 21, 638, 10.1111/resp.12707

Corrigan, 2011, Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses, J Allergy Clin Immunol, 128, 116, 10.1016/j.jaci.2011.03.043

Kang, 2005, Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles, Am J Respir Cell Mol Biol, 33, 290, 10.1165/rcmb.2005-0003OC

Ikeda, 2003, Mast cells produce interleukin-25 upon Fcepsilon RI-mediated activation, Blood, 101, 3594, 10.1182/blood-2002-09-2817

Angkasekwinai, 2007, Interleukin 25 promotes the initiation of proallergic type 2 responses, J Exp Med, 204, 1509, 10.1084/jem.20061675

Ballantyne, 2007, Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma, J Allergy Clin Immunol, 120, 1324, 10.1016/j.jaci.2007.07.051

Barlow, 2012, Innate IL-13–producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity, J Allergy Clin Immunol, 129, 191, 10.1016/j.jaci.2011.09.041

Rickel, 2008, Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities, J Immunol, 181, 4299, 10.4049/jimmunol.181.6.4299

Cheng, 2014, Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma, Am J Respir Crit Care Med, 190, 639, 10.1164/rccm.201403-0505OC

Huang, 2015, IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal ischemic/reperfusion injury, J Am Soc Nephrol, 26, 2199, 10.1681/ASN.2014050479

Barlow, 2011, Nuocytes: expanding the innate cell repertoire in type-2 immunity, J Leukoc Biol, 90, 867, 10.1189/jlb.0311160

Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015

Préfontaine, 2010, Increased IL-33 expression by epithelial cells in bronchial asthma, J Allergy Clin Immunol, 125, 752, 10.1016/j.jaci.2009.12.935

Barlow, 2013, IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction, J Allergy Clin Immunol, 132, 933, 10.1016/j.jaci.2013.05.012

Kurowska-Stolarska, 2009, IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation, J Immunol, 183, 6469, 10.4049/jimmunol.0901575

Johnston, 2017, Understanding interleukin 33 and its roles in eosinophil development, Front Med, 4, 51, 10.3389/fmed.2017.00051

Moussion, 2008, The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?, PLoS One, 3, e3331, 10.1371/journal.pone.0003331

Borish, 2016, The immunology of asthma: Asthma phenotypes and their implications for personalized treatment, Ann Allergy, Asthma Immunol, 117, 108, 10.1016/j.anai.2016.04.022

Cayrol, 2009, The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1, Proc Natl Acad Sci USA, 106, 9021, 10.1073/pnas.0812690106

Stolarski, 2010, IL-33 exacerbates eosinophil-mediated airway inflammation, J Immunol, 185, 3472, 10.4049/jimmunol.1000730

Sehmi, 2016, Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma, Clin Exp Allergy, 46, 793, 10.1111/cea.12695

Préfontaine, 2009, Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells, J Immunol, 183, 5094, 10.4049/jimmunol.0802387

Moffatt, 2010, a large-scale, consortium-based genomewide association study of asthma, N Engl J Med, 363, 1211, 10.1056/NEJMoa0906312

Chen, 2017, Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in asthmatic subjects, Am J Respir Crit Care Med, 196, 700, 10.1164/rccm.201612-2427OC

Nakanishi, 2013, IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis, PLoS One, 8, e78099, 10.1371/journal.pone.0078099

Takai, 2012, TSLP expression: cellular sources, triggers, and regulatory mechanisms, Allergol Int, 61, 3, 10.2332/allergolint.11-RAI-0395

Verstraete, 2017, Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma, Nat Commun, 8, 14937, 10.1038/ncomms14937

Dong, 2016, Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption, Sci Rep, 6, 39559, 10.1038/srep39559

Leonard, 2002, TSLP: finally in the limelight, Nat Immunol, 3, 605, 10.1038/ni0702-605

Torgerson, 2011, Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations, Nat Genet, 43, 887, 10.1038/ng.888

Ying, 2005, Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity, J Immunol, 174, 8183, 10.4049/jimmunol.174.12.8183

Shikotra, 2012, Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma, J Allergy Clin Immunol, 129, 104, 10.1016/j.jaci.2011.08.031

Nagakumar, 2016, Type 2 innate lymphoid cells in induced sputum from children with severe asthma, J Allergy Clin Immunol, 137, 624, 10.1016/j.jaci.2015.06.038

Bal, 2016, IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs, Nat Immunol, 17, 636, 10.1038/ni.3444

Smith, 2016, Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia, J Allergy Clin Immunol, 137, 75, 10.1016/j.jaci.2015.05.037

Cockcroft, 2005, The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen, Allergy, 60, 56, 10.1111/j.1398-9995.2004.00612.x

Zhou, 2005, Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice, Nat Immunol, 6, 1047, 10.1038/ni1247

Shi, 2008, Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells, Clin Immunol, 129, 202, 10.1016/j.clim.2008.07.015

Zhang, 2011, A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells, Clin Exp Immunol, 164, 256, 10.1111/j.1365-2249.2011.04328.x

Chen, 2013, Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite, PLoS One, 8, e51268, 10.1371/journal.pone.0051268

Cheng, 2013, Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma, J Allergy Clin Immunol, 132, 455, 10.1016/j.jaci.2013.05.011

Baatjes, 2015, Treatment with anti-OX40L or anti-TSLP does not alter the frequency of T regulatory cells in allergic asthmatics, Allergy, 70, 1505, 10.1111/all.12708

Beale, 2014, Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation, Sci Transl Med, 6, 256ra134, 10.1126/scitranslmed.3009124

Wang, 2016, IL-25 promotes Th2 immunity responses in asthmatic mice via nuocytes activation, PLoS One, 11, e0162393, 10.1371/journal.pone.0162393

Kim, 2012, Beneficial effect of antiinterleukin-33 on the murine model of allergic inflammation of the lower airway, J Asthma, 49, 738, 10.3109/02770903.2012.702841

Mizutani, 2013, Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice, Immunology, 139, 205, 10.1111/imm.12071

Jang, 2014, Additive antiallergic effects of antiinterleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma, Cent Eur J Immunol, 39, 426, 10.5114/ceji.2014.47724

Lee, 2014, Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma, Exp Lung Res, 40, 66, 10.3109/01902148.2013.870261

Zeng, 2015, IL-33 receptor (ST2) signalling is important for regulation of Th2-mediated airway inflammation in a murine model of acute respiratory syncytial virus infection, Scand J Immunol, 81, 494, 10.1111/sji.12284

Al-Sajee, 2017, Expression profile of interleukin-33 (IL-33), interleukin-1 receptor family member (IL1RL1, ST2) and thymic stromal lymphopoeitin (TSLP) in airway epithelium from asthmatic subjects after allergen challenge, Am J Respir Crit Care Med, 195, A3127

Busse, 2013, Randomized, double-blind, placebo-controlled study of brodalumab, a human Anti–IL-17 receptor monoclonal antibody, in moderate to severe asthma, Am J Respir Crit Care Med, 188, 1294, 10.1164/rccm.201212-2318OC

Kurowska-Stolarska, 2008, IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4, J Immunol, 181, 4780, 10.4049/jimmunol.181.7.4780

Coyle, 1999, Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses, J Exp Med, 190, 895, 10.1084/jem.190.7.895

Miller, 2011, Role of IL-33 in inflammation and disease, J Inflamm (Lond, 8, 22, 10.1186/1476-9255-8-22

Miller, 2011, The IL-33/ST2 pathway — a new therapeutic target in cardiovascular disease, Pharmacol Ther, 131, 179, 10.1016/j.pharmthera.2011.02.005